Skip to content
Datasets/TARGET-OS

Osteosarcoma

MixedMachine-extracted
TARGETAvailable from GDC

Can it answer your research question?

3 of 6 supported
  • Overall survival

    Supported

    Vital status and time are populated; median follow-up 3.0 years; 277 cases with follow-up; endpoints: overall survival, progression-free interval.API

  • Progression or recurrence

    Supported

    A time to event is derivable: progression-free interval; progression_or_recurrence is informative for 33% of cases.API

  • Treatment response

    Not supported

    treatment_outcome is populated for no case in the harmonized records.API

  • Which drug was given

    Limited

    therapeutic_agents is recorded for 13% of cases.API

  • Stage-adjusted modelling

    Not supported

    ajcc_pathologic_stage is informative for no case in the harmonized records.API

  • Analysis by race or ethnicity

    Supported

    Race is informative for 66% of cases.API

Judged from the repository’s own field completeness (thresholds). “Not measured” means we have not probed that field for this record, not that the data lack it.

At a glance

Every percentage is the repository’s own record of what is filled in
CasesAPI
383
Measurement types
8
4,314 files, 26 TB
Follow-upAPI
3.0 years
for 277 of 383 cases; overall survival, progression-free interval
Treatment responseAPI
Not recorded

SubjectCALC

Bone

As filed by the repository

Osseous and Chondromatous NeoplasmsNot ReportedBones, joints and articular cartilage of other and unspecified sitesBones, joints and articular cartilage of limbs

Who is in the cohortAPI

A usable value“Not reported” or “unknown”No value recorded
  • Sex172 male · 133 female · 78 no value recorded
  • Race172 white · 41 asian · 34 black or african american · 6 2 other · 40 unknown · 12 not reported · 78 no value recorded
  • Ethnicity159 not hispanic or latino · 43 hispanic or latino · 75 not reported · 28 unknown · 78 no value recorded
  • Vital status171 alive · 105 dead · 24 not reported · 5 unknown · 78 no value recorded

Age at diagnosis

Median 15, middle half 12–18, range 4–89 years across 305 cases.

What was measured, and on how many

8 measurement types, none covering the whole cohort.

  • Whole exome sequencing113 of 383 · 30%
  • Whole genome sequencing58 of 383 · 15%
  • Bulk RNA sequencing88 of 383 · 23%
  • Targeted DNA panel sequencing168 of 383 · 44%
  • SNP genotyping array (copy number, germline)88 of 383 · 23%
  • DNA methylation array86 of 383 · 22%
  • Clinical293 of 383 · 77%
  • Somatic Structural Variation3 of 383 · <1%
Platform, files and data levels
AssayPlatformFilesLevels
Whole exome sequencingAPIillumina1,638-
Whole genome sequencingAPIillumina277-
Bulk RNA sequencingAPIillumina616-
Targeted DNA panel sequencingAPIillumina1,186-
SNP genotyping array (copy number, germline)APIillumina333-
DNA methylation arrayAPIillumina258-
ClinicalAPI-4-
Somatic Structural VariationAPI-6-
How complete all 29 clinical fields are - 0 informative for at least 80% of cases

A field counts as informative only when it holds a real value. “Not reported” blocks an analysis just as a missing field does. Fields marked 1:n can hold several records per case, so they show the share of cases with any record.

Informative - a usable valuePresent but uninformative - “not reported” or “unknown”Absent - no value recorded

Outcome

  • Vital statusAPI72%
  • Cause of deathAPI0%
  • Progression or recurrenceAPI0%
  • Last known disease statusAPI0%

Follow-up

  • Progression at follow-upAPI33%
  • Disease response at follow-upAPI0%
  • ECOG performance statusAPI0%

Treatment

  • Treatment givenAPI68%
  • Therapeutic agents1:nAPI13%
  • Prior treatmentAPI0%
  • Treatment typeAPI0%
  • Treatment outcomeAPI0%
  • Regimen or line of therapyAPI0%

Staging

  • AJCC pathologic stageAPI0%
  • AJCC clinical stageAPI0%

Diagnosis

  • Primary diagnosisAPI80%
  • Tissue or organ of originAPI74%
  • Prior malignancyAPI0%
  • Synchronous malignancyAPI0%

Pathology

  • Morphology (ICD-O)API80%
  • Classification of tumorAPI77%
  • Tumor gradeAPI0%

Demographics

  • Sex at birthAPI80%
  • RaceAPI66%
  • EthnicityAPI53%
  • Population groupAPI0%
  • Country of residenceAPI0%

Exposure

  • Tobacco smoking statusAPI0%
  • Alcohol historyAPI0%

Access

MixedSome components are open; others need approval.

Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required

Open components
708 open-access files
Controlled components
3,606 controlled-access files
Typical turnaround
days to a few weeks after signing official approval
License
NIH Genomic Data Sharing Policy terms
Citation requirement
Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.

What it is good for

Written and checked by a reviewer, not generated from metadata.

No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.

What it cannot tell you

Written by a reviewer against the source, not inferred from what is missing.

No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.

Who has used it

Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.

Analyzed the dataCALC2
244
accession in the methods; 93% of a 29-article sample really cited it
Declared using it
30
named in a data availability statement
Cited the paper
643
attention to the publication, not reuse of the data
Against expectation
As expected or above
about 233 articles expected; index 0.06

What articles did with it

Only the last row counts as reuse. Where the accession appears in an article tells us what the authors did with the data.

  • Cited the paper643
  • Mentioned the dataset42
  • Accession found in text22
  • Declared using it30
  • Analyzed the data244

Against comparable datasets

244 articles analyzed these data. About 233 would be expected. The expectation comes from a model of size, age, breadth and access tier.

  • Analyzed it244
  • Expected~233
How this count was corrected
Europe PMC returned 262 articles for METHODS:"TARGET-OS", but it indexes the hyphen in TARGET-OS as a word break, so that query also matches the two words in ordinary prose. Of 29 sampled articles whose full text we could read, 27 contained the literal accession (78-98%, 95% interval). The published figure is the raw count scaled by that fraction.
Reuse assessment
  • Reuse is within the expected range for comparable datasets (index +0.06).

Compared against 132 datasets in this corpus with a citable accession and sufficient metadata. See Methods for the model.

Articles that analyzed the data

Examples, not the full list. 116 articles matching this dataset's accession search were retrieved and graded individually; these are the strongest of those.

Deep-review sample: author overlap and funding were checked only for the 10 articles listed here, not for every article examined. Of the 10 that analyzed the data, 8 of the 10 we could check had no author in common with the generating team, and 5 of the 10 we could check were themselves NCI-funded. These are sample counts, not population estimates.

Community examples

Share your example

Analyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.

Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.

Start here

Starter code generated from this record’s own identifiers, then the access steps.

Get the data in code

GDC: list open files and download thempython

Open-access files need no account. Controlled files need an approved dbGaP request and a token passed to gdc-client.

import json, requests

PROJECT = "TARGET-OS"
filters = {"op": "and", "content": [
    {"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
    {"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
          "fields": "file_id,file_name,data_category,data_type,file_size",
          "size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")

# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
    fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txt
GDC: clinical table for every casepython
import json, requests

filters = {"op": "in", "content": {"field": "project.project_id", "value": ["TARGET-OS"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
          "fields": ",".join([
              "submitter_id", "demographic.vital_status", "demographic.days_to_death",
              "diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
              "diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("TARGET-OS_clinical.tsv", "w").write(tsv)
This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-target-os.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
    print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'

Access steps

  1. 1
    Open the project in the GDC Data PortalFor people5 minutes

    Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.

    https://portal.gdc.cancer.gov/projects/TARGET-OS

    Generated from repository policy. Check the linked policy before downloading.

  2. 2
    Download the open files without an accountFor peopleminutes to hours, by cohort size

    708 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.

    gdc-client download -m gdc_manifest.txt
    https://gdc.cancer.gov/access-data/gdc-data-transfer-tool

    Generated from repository policy. Check the linked policy before downloading.

  3. 3
    Request controlled access through dbGaPFor peopledays to a few weeks after signing official approval

    3,606 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs000468.

    Requires: eRA Commons account, institutional signing official approval, dbGaP data access request for phs000468

    https://gdc.cancer.gov/access-data/obtaining-access-controlled-data

    Generated from repository policy. Check the linked policy before downloading.

  4. 4
    Download controlled files with your tokenFor people

    An approved request yields a token. The same manifest fetches nothing controlled without it.

    Requires: approved dbGaP request, GDC authentication token

    gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt
    https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000468

    Generated from repository policy. Check the linked policy before downloading.

  5. 5
    Query the project from code, with no credentialsFor agents

    The file index is public even where files are not, so an agent can size the cohort before anyone requests access.

    curl -s 'https://api.gdc.cancer.gov/files' --get \
      --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["TARGET-OS"]}}' \
      --data-urlencode 'fields=file_id,file_name,data_type' \
      --data-urlencode 'size=10000' --data-urlencode 'format=TSV'
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

  6. 6
    Pass the token when the agent needs controlled filesFor agents

    Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.

    Requires: GDC authentication token

    curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

Provenance

All of it, and more, is in this record’s JSON.

Identifiers

Versions and verification

Released
1 Jan 2009
Metadata retrieved
18 Sept 2026
Review status
Machine-extracted
Data generation funding
Funded data generation

Funding

Awards resolved through NIH RePORTER. Awards that paid to generate these data are listed apart from awards that paid to reuse them. Both are returns on NCI investment, but different ones.

Funded data generation

  • P30CA021765Cancer Biology (CBP)Douglas R. Green, Elizabeth FoxFY1985-2026API2
  • R01CA168875Molecular Targeted Therapy for RetinoblastomaMichael A DyerFY2012-2016API

Funded reuse of these data

  • R01CA202987Functions of Nonclassical Monocytes in the VasculatureCatherine C HedrickFY2016-2020API
  • K08CA267057Defining Pre-treatment Correlates of Patient GD2 CAR T Cell Exhaustion and Memory Using Multi-Dimensional Immune ProfilingSneha RamakrishnaFY2022-2026API
  • F30CA271797Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T CellsTara MurtyFY2022-2025API
  • R50CA211461Open Software and Resource Development Leveraging Next-gen Sequencing Data to Facilitate Computational Analysis of Cancer BiologyBrian HaasFY2016-2020API
  • K08CA273527Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesisAnne Van ArsdaleFY2022-2026API
  • R21CA267914DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMAJennifer J Kohler, Jason YusteinFY2022-2023API
  • R01CA229510Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapyChristiane QuerfeldFY2019-2023API
  • R01CA215452Identifying and targeting oncogenic Myc enhancer control in pediatric tumorsThomas Westbrook, Charles Yang LinFY2017-2021API

Funded infrastructure or harmonization

  • U10CA098543Children's Oncology Group Chair's GrantPETER C. ADAMSON, GREGORY H REAMANFY2003-2013API
  • U24CA224331Cancer Immune Monitoring and Analysis CenterFRANK S HODI, Catherine Ju-Ying WuFY2017-2026API
  • U24CA224316Cancer Immunologic Data Commons (CIDC) Supplement RequestEthan Cerami, Franziska MichorFY2017-2022API
  • U24CA224309Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)Sean Curtis Bendall, Holden T. MaeckerFY2017-2026API
  • U01CA224766Protective Role of Nonclassical Monocytes in Immunotherapies for Solid CancersCatherine C Hedrick, Rosandra Natasha KaplanFY2018-2021API
  • P30CA124435BiostatisticsMANISHA DESAI, Ryan D. LeibFY2007-2026API
  • P50CA217694Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial SarcomaMarc Ladanyi, SAMUEL SINGERFY2018-2025API
  • P30CA008748Antitumor AssessmentElisa de Stanchina, FRANCESCA M GANYFY1985-2026API
  • U24CA258406The Integrative Genomics Viewer (IGV) for Cancer ResearchJILL P. MESIROV, James Thomas RobinsonFY2021-2025API
  • U24CA180922Trinity: Transcriptome assembly for genetic and functional analysis of cancerBrian Haas, Eric BanksFY2013-2022API

and 1 more

For softwarerecord JSON